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Cell-specific metabolomic 
responses to injury: novel insights 
into blood-brain barrier modulation
Sheng-Fu Huang  1,2,5, Sabrina Fischer  1,3,5, Alexey Koshkin1,2, Endre Laczko  4, 
David Fischer4 & Omolara O. Ogunshola  1,2 ✉
On one hand blood-brain barrier (BBB) disturbance aggravates disease progression, on the other it 
prevents drug access and impedes therapeutic efficacy. Effective ways to modulate barrier function 
and resolve these issues are sorely needed. Convinced that better understanding of cell-oriented BBB 
responses could provide valuable insight, and the fact that metabolic dysregulation is prominent in 
many vascular-related pathological processes associated with BBB disturbance, we hypothesized that 
differential cell-specific metabolic adaptation majorly influences physiological and pathological barrier 
functionality. Untargeted liquid chromatography–mass spectrometry (LC-MS) metabolomic profiling 
was used to obtain individual biochemical fingerprints of primary astrocytes (AC) and brain endothelial 
cells (EC) during normoxic conditions and increasing hypoxic/ischemic injury and thus a functional 
readout of cell status. Bioinformatic analyses showed each cell had a distinct metabolic signature. 
Corroborating their roles in BBB and CNS protection, AC showed an innate ability to dynamically alter 
their metabolome depending on the insult. Surprisingly, in complete contrast, EC largely maintained 
their normoxic characteristics in injury situations and their profiles diverged from those of non-brain 
origin. Tissue specificity/origin is clearly important when considering EC responses. Focusing on energy 
capacity and utilization we discuss how cell-specific metabolic adaptive capabilities could influence 
vascular stability and the possibility that altering metabolite levels may be an effective way to modulate 
brain EC function. Overall this work novel insight into cell-associated metabolic changes, and provides a 
powerful resource for understanding BBB changes during different injury scenarios.
Stability of the neurovascular unit (NVU) as a result of proper blood-brain barrier (BBB) function is essential 
for brain and whole body homeostasis. BBB dysfunction occurs in many brain pathologies and increased BBB 
permeability directly correlates with poor disease outcome1–3. In contrast the BBB also actively prevents drugs 
aimed at improving neuronal function from gaining access to the brain tissue. It seems clear that patient recovery 
after injury would benefit from controlled modulation of BBB permeability. Unfortunately this goal remains an 
unsolved challenge.
Located at the level of the impermeable brain microvasculature, the BBB maintains CNS homeostasis by reg-
ulating the passage of ions and molecules between the brain and circulatory system1,3. The brain endothelial 
cells (EC) that form the barrier are supported by perivascular cells, namely astrocytes (AC) and pericytes, that 
secrete growth factors and substrates to sustain proper barrier function1,3. We still have limited understanding of 
how these barrier-associated cells respond individually or interact concertedly - physiologically or pathologically. 
Particularly how changes in cell-specific metabolism relate to barrier homeostasis remains largely unclear. Better 
insight could offer more innate, and potentially highly effective, ways to modulate barrier characteristics.
To date studies on endothelial metabolism have focused on peripheral EC isolated from lung4, arteries5 and 
retina6 as well as human umbilical vein EC (HUVEC)7. Mitochondrial respiration in these non-brain EC is rela-
tively low compared to other cell types. Most quiescent non-brain EC are primarily glycolytic, using β-fatty acid 
oxidation to generate ATP, maintain redox homeostasis as well as support nucleotide and protein synthesis8. This 
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basal metabolic profile becomes even more glycolytic during injury with higher activity in glutamate and pentose 
phosphate pathways (PPP) enabling replenishment of critical energy stores to support hypoxic angiogenesis9,10. 
Similar mechanisms are also activated during cancer EC proliferation with glutamate and glucose being utilized 
to increase energy generation and nucleotide synthesis during hypoxia and ischemia11.
Detailed metabolomic profiling of brain microvascular ECs has not been published to date. The brain 
endothelium is unique having a distinct proteomic composition and exhibiting unexpected molecular alterations 
during injury such as elevated protein synthesis12, suggesting specialized processes continue despite challenging 
conditions. Furthermore, angiogenesis, the state that leads to increased vascular permeability, is activated mainly 
during prolonged or extreme injury conditions in brain EC13,14. These unique properties most likely augment 
their critical barrier role and suggest a detailed study is warranted to better understand their unique properties.
AC influence both BBB function and the neurovascular unit (NVU) as a whole. Since their endfeet con-
tact both vessel walls and neurons, they are important mediators of signals to and from the different cellular 
compartments1,15,16. AC metabolism is tuned to constantly facilitate brain homeostasis. Highly activated energy 
production, via TCA and glutamate recycling, enables AC to deal with high metabolic stress17. AC also boost gly-
cogen degradation to replenish energy stores18,19 and generate glutathione and NAD+ to maintain cellular redox 
balance20,21 during brain injury. This inherent ability to rapidly adapt metabolically is crucial for surrounding 
neurons22 but whether similar or distinct metabolic coordination occurs between AC and nearby capillaries is 
unknown.
We aimed to obtain detailed insight into individual AC and EC responses to environmental change by profil-
ing BBB cell-specific metabolomic changes during different conditions. A number of challenges are standardly 
encountered when studying the BBB in vivo but in particular, it is problematic to understand where specific 
signals originate and/or the effects of changing conditions on individual cell populations. To circumvent these 
obstacles we performed metabolomic profiling of unpassaged primary AC and primary brain microvascular EC. 
Untargeted liquid chromatography–mass spectrometry (LC-MS) provided a global overview of cellular metabo-
lite composition before and after exposure to increasing severities of hypoxia and/or ischemia simulating various 
pathological situations. By comparing baseline (normoxic) and injury-mediated changes in metabolite levels 
we show that AC and brain EC profiles differ significantly and that brain EC profiles also diverge from those of 
non-brain origin. Assessing key metabolic pathways involved in energy capacity and utilization, we conclude 
that stressed EC are likely to be highly reliant on metabolic support from surrounding cells. Indeed, the observed 
dynamic adaptive capacity of AC during insult presumably provides an important metabolic reservoir and under-
lies their ability to improve EC function and integrity. Overall, this study provides new insight into cell-specific 
metabolic changes, and provides a powerful resource for understanding BBB changes during different injury 
scenarios.
Material and Methods
All animal experimental protocols in this study were approved by the University of Zurich Animal Protection 
Office and Swiss Veterinary Office of Canton Zurich, and conform to Swiss Animal Protection guidelines and 
regulations (Swiss Animal Protection and Swiss Animal Act and Ordinance).
Primary cell isolation. All cell culture media and reagents were obtained from Gibco® (Life Technologies, 
Zug, Switzerland) and Sigma-Aldrich (Buchs, Switzerland). Primary rat astrocytes (AC) were isolated from neo-
natal pups as described previously23, cultured in DMEM containing 5 mM glucose and supplemented with 10% 
FBS and 50 µg/ml gentamycin sulfate. Primary rat brain microvascular endothelial cells (EC) were isolated from 
8–10 week old animals according to Coisne et al.24. Isolated EC were cultured in endothelial media (DMEM 
(5 mM glucose) supplemented with 20% newborn calf serum, 1x BME amino acids, 1x vitamin solution, 2 mM 
L-glutamine, 1 ng/ml bFGF, 50 µg/ml gentamycin sulfate) and plated on collagen-IV coated dishes. EC reached 
100% confluency within 7 days and were used without passaging. Isolation purity was ≥95% as analyzed by 
immunostaining for standard cell markers (Fig. S1a). AC were identified by high GFAP expression and absence/
low expression of NG2 and PDGFRβ (pericyte markers) and PECAM-1 (EC marker). Purity of EC monolayers 
was assessed by absence of GFAP, NG2, α-smooth muscle actin (smooth muscle cells) as well as localization of 
tight junction proteins (occludin, ZO-1 and Claudin-5) and PECAM-1 to cell-cell borders.).
O2 deprivation and ischemic treatment. O2 deprivation experiments were carried out in purpose-built 
hypoxic glove-box chambers (InVivO2 400, Ruskinn Technologies, Pencoed, UK) maintained at 37 °C with 5% 
CO2. O2 concentration was constantly monitored with an internal O2 sensor. To enable direct comparison of all 
results, both cell types were preincubated in MS (mass spectrometry) media (DMEM + 10% calf serum + BME 
amino acids, vitamin solution, 2 mM L-glutamine, 1 ng/ml bFGF and 50 µg/ml gentamycin sulfate) for 6 h. Fresh 
media was the applied to all plates immediately before exposure to normoxic (NX, 21% O2), hypoxic (HX, 1% 
O2) or near anoxic (AX, 0.2% O2) conditions for 24 h. Glucose-free media was used to simulate ischemia in vitro 
(oxygen-glucose deprivation (OGD).
Specific quantitative Biochemical analysis. After exposure cell lysates were collected. ATP levels were 
detected using a fluorometric kit (Abcam, range = 0.1–1 nmol, sensitivity < 1 µM). Glucose levels were measured 
using a colorimetric kit (Abcam, range = 1–1000 µM, sensitivity = 1 µM). Cellular glycogen was detected using a 
fluorometric assay (Abcam, range = 0.4 µg/ml − 2000 µg/ml, sensitivity > 0.4 µg/ml). Samples were measured in 
duplicate and normalized to total cell counts obtained using DAPI staining and EVOS FL Auto Imaging System 
(Thermo Fisher Scientific). Four independent experiments were performed, N = 4.
Metabolite extraction. After exposure to different conditions cells were washed twice with ice-cold 
5 mM NH4HCO3 solution and residual liquid was removed. Cell metabolism was immediately quenched 
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in 100 µl 80% methanol (−20 °C) containing 20 µg/ml C13/N15 labelled amino acid mixture (Cortecnet, 
Voisins-Le-Bretonneux, France) as the internal standard. Cells were scraped from the dish and incubated for 
10 min on ice. After centrifugation (6000 g for 5 min at 4 °C) the supernatant containing the metabolites was 
lyophilized and stored at −80 °C until measurement. Four independent experiments were performed, N = 4.
Untargeted LC-MS measurements. All mass spectrometry measurements and analyses were conducted 
in cooperation with the Functional Genomics Center Zurich (FGCZ), University of Zurich. Lyophilized metab-
olite pellets were resuspended in 20 µl ddH2O and transferred to 96-well plates. Samples were then diluted 1:5 in 
injection solution (90% acetonitrile, 10% methanol, 50 mM ammonium acetate, pH 9) and centrifuged. 30 µl of 
supernatant (duplicate) were transferred to a fresh 96-well plate and directly analyzed on a nanoACQUITY sys-
tem coupled to a Synapt G2HD mass spectrometer (Waters Corp., Milford, USA). Chromatographic separation 
of metabolites was performed on a 0.2 µm × 150 mm BEH amide column using a 10 minute linear gradient of 
90% to 50% acetonitrile, 0.5 mM ammonium acetate, pH 9. All analyses were done in negative mode using 1.2 kV 
capillary voltage, 30 V sampling cone voltage and 3 V extraction cone voltage. The source temperature was set to 
100 °C and Nano Flow Gas, i.e. sheet gas flow, was applied. For quality control we spiked a mix of C13/N15 labelled 
amino acids during the extraction to follow the overall performance of the LC-MS method and data normaliza-
tion. To estimate the overall quality of the quantification, we determined the RSD of two major metabolites for 
the reported HILIC methods, namely aspartic acid and glutamic acids. An RSD of 25.7% without total ion count 
normalization and 22.3% after normalization was measured for glutamic acid. For aspartic acid, RSD before nor-
malization was 25.6% and 22.3% after normalization.
Data analysis and processing. Waters raw data were first converted to centroid mode and further pro-
cessed into vendor independent netCDF format using DataBridge (Masslynx, Waters Corp.). Untargeted metabo-
lomics data matrix comprising of accurate mass/retention time information, and ion counts for each sample were 
calculated using the data processing tool cosmiq25. Signal-to-noise ratio (SNR) of mass peak detection was set to 
3, SNR for chromatographic peak detection was set to 10 and a m/z bin size of 0.003 Da was chosen as parameters 
for cosmiq. For metabolite annotation, the results were first matched to a list of metabolites with known retention 
time and mass. For annotation of unknown metabolites, the list of accurate masses was matched to the KEGG 
database assuming [M-H]- adducts26. Database hits within a mass window of 0.01 Da were considered.
Data normalization strategy. To compare the relative metabolite quantities between the different treat-
ments and cell types, we performed a normalization approach according to the sum of all detected metabolite 
ion counts as previous27. This was important as hypoxia and ischemia differentially alter protein amounts, pro-
liferation rates and DNA content. AC and EC also have significantly different cell size. The strategy avoids these 
confounding factors as it is based on the assumption that the total number of cells used for extraction is reflected 
by the total amount of metabolites and hence can be estimated by the sum of measured ion counts. One of the 
NX + Glc EC samples was randomly chosen as reference and the normalized ion intensity for each metabolite was 
calculated by dividing the observed ion intensity by the factor Σis/ Σir, where Σis is the summed ion intensity for 
each individual sample and Σir is the summed ion intensity of the reference sample.
Pathway analyses. Statistically significant metabolites were analyzed using the KEGG metabolic pathway 
map26 and MetaboAnalyst28. The KEGG pathway map was retrieved in the KGML data format and imported 
into Cytoscape29 using the KGMLReader tool. Fold changes and significance values of the annotated metabolites 
were mapped on this global pathway map. A list of KEGG IDs was uploaded to the Pathway Analysis tool of 
MetaboAnalyst and a list of significant pathways was retrieved using the following parameters: Rattus norvegicus 
pathway library, hypergeometric test and relative-betweenness centrality.
Bioinformatics and statistics. The normalized data matrix with ion counts of annotated metabolites was 
used for subsequent analysis in R. For the calculation of principal components analysis (PCA), the dudi.pca func-
tion from the CRNA package ade4 was used. A colored correlation matrix and hierarchical clustering heatmap 
were used to visualize the maximal metabolic alterations between each group. For the correlation matrix, the 
Pearson correlation coefficients were calculated for median values of metabolite abundance using R version 3.3.2., 
while for hierarchical clustering fold change (FC) based on metabolite abundance values were used. In the hier-
archical clustering heatmap, positive values indicate the level a specific metabolite is increased, while negative 
values indicate the amount a specific metabolite is decreased. The LC-MS abundance data set was imported into 
R software for heatmap generation. Pathway activity heatmaps were generated for metabolites with intensity fold 
change over NX + Glc were greater than 1.3 (upregulated pathways) or lower than −1.3 (downregulated path-
ways). The respective metabolites were selected for pathway enrichment analysis (MetaboAnalyst, www.metabo-
analyst.ca) to calculate -Log10(P) for each covered metabolic pathway. Venn diagrams were then generated for 
these pathway specific lists using InteractiVenn30. All results are expressed as mean ± SD. Statistical significance 
was either assessed using unpaired student’s t-test or one-way ANOVA for comparison within one group and 
two-way ANOVA for comparison between different groups using GraphPad Prism 7 software (La Jolla, CA). 
Bonferroni’s post-hoc test was used for all analyses. A p-value below 0.05 was considered significant.
Results
Metabolome compositions differ strongly for both cell type and insult severity. Using an untar-
geted LC-MS based approach we compared the metabolic profiles of primary rat brain microvascular endothelial 
cells (EC) and astrocytes (AC) after exposure to normoxia, hypoxia or near anoxia for 24 h in glucose con-
taining media or glucose-free media (to simulate ischemia in vitro). With a combination of known standard 
retention times and accurate mass matching to the KEGG library 372 metabolites were annotated, allowing a 
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global overview of cellular metabolism. Principal component analysis (PCA) was first performed to assess over-
all metabolome differences between the groups. Figure 1a shows graphical representation of PCA scores for all 
treatments of both AC (circles) and EC (squares). The plot shows the four biological replicates clustering closely 
together implying good reproducibility of the observed changes (Fig. 1a). The axes represent the major principal 
components (PC) of the dataset defining the directions of the highest variance/difference i.e. where the metabo-
lome is most different. Distinct separation of AC versus EC data points on the PC1 axis shows the cell type makes 
the largest contribution to metabolome composition. Insult severity (PC2 axis) is the second most important 
parameter affecting metabolome composition. Close clustering of the O2 deprivation groups for both cells on PC2 
Figure 1. Metabolome compositions differ strongly for both cell type and insult severity. (a) Principal 
component analysis of the metabolomes of AC (circles) and EC (squares) exposed to normoxia, hypoxia and 
near anoxia in presence and absence of glucose. Axes represent the first three principal components (PC) of the 
dataset and their contribution to overall metabolome variance in percent (%). (b) Correlation matrix plot of all 
AC and EC conditions. The Pearson correlation coefficients were calculated by log2 transformed ratios of the 
median values of fold changes and are represented by gradient colors as indicated in the color key. Correlations 
less than 0.6 are shown in gray. (c) Hierarchical clustering heatmap of different injury conditions in AC and 
EC samples. Metabolites significantly decreased are displayed in green and those significantly increased 
displayed in red. The brightness of each color corresponds to the magnitude of the difference when compared 
with average values. Normoxia (NX), hypoxia (HX) and near anoxia (AX) in presence and absence of glucose 
(±Glc). To enable comparison of data between the cell types, the metabolite intensities were normalized to total 
ion counts. n = 4.
5SCIENTIFIC REPORTS |         (2020) 10:7760  | https://doi.org/10.1038/s41598-020-64722-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
indicates that only small changes in the metabolome occur during insult. In contrast oxygen-glucose deprivation 
(OGD) induces a spread of the different exposures along the second axis demonstrating more profound changes 
(Fig. 1a). Pearson correlation matrix confirmed the similarities between AC and EC under different injury con-
ditions and shows the different cell types have different metabolic constitutions (Fig. 1b). To further assess these 
changes, a hierarchical clustering heatmap was constructed comparing the different AC and EC metabolic com-
positions to their own baseline conditions (NX + Glc). Clustering of conditions within the hierarchical tree shows 
similar dynamic behaviour and emphasizes that glucose deprivation dramatically alters metabolite abundance 
(Fig. 1c). Thus AC and EC metabolomes are quite different under all conditions and, surprisingly, sole oxygen 
deprivation is not a strong modulator of metabolome composition.
Baseline metabolomic profiles: AC have prominent sugar metabolism whereas EC exhibit 
strong purine and amino acid metabolism. To identify differentially activated pathways in EC and AC, 
we determined the main metabolites accounting for cell type specific differences under normoxic conditions. 
From a comprehensive list of all detected metabolites, the ratio of metabolite abundance of AC to EC was cal-
culated for baseline conditions (NX + Glc). Fold changes and p-values were mapped on the global metabolism 
KEGG pathway map (Fig. 2a). Metabolites increased in AC compared to EC are shown in red circles whereas 
metabolites higher in EC are blue. The circle size reflects the fold change with dark colors indicating significant 
alterations and light colors insignificant ones. The map shows that many AC metabolites are expressed at sig-
nificantly higher levels than EC, particularly in pathways that account for carbohydrate metabolism and TCA 
cycle (Fig. 2a). In contrast, EC accumulate metabolites involved in nucleotide and lipid metabolism. To further 
characterize the differentially active pathways in the two cell types enrichment analysis was performed using the 
MetaboAnalyst tool and -Log10(P) values were calculated. The data is presented in a heatmap that depicts the 
major active pathways in AC and EC in relation to each other (Fig. 2b). Correlating well with the KEGG analysis 
results we again identified pathways linked to carbohydrate metabolism from top hits for AC including galactose, 
starch and sucrose, amino sugar and nucleotide sugar and fructose metabolism, as well as glycolysis and citrate 
cycle. In contrast, EC metabolites of the purine metabolism pathway as well as different amino acid pathways such 
as tyrosine, D-glutamine/D-glutamate and arginine/proline metabolism were more overrepresented compared 
to AC. In summary AC had high levels of metabolites related to sugars and activated sugars compared to EC, 
whereas EC nucleotides and select amino acid metabolites were more abundant in relation to AC.
Energy capacity during normoxic conditions in AC and EC. To better understand the individual cellu-
lar capacity for energy generation we compared the levels of different metabolites involved in glucose metabolism. 
Since the LC-MS could not distinguish molecules with the same molecular formula such as hexoses (fructose, 
galactose and glucose), we used independent assays to accurately measure glucose and glycogen levels. Although 
similar amounts of glucose were detected in AC and EC (Fig. 3a), AC maintained large glycogen stores whereas 
EC clearly did not (Fig. 3c). In agreement higher levels of UDP-glucose, the major glycogen building block, were 
observed in AC (Fig. 3b). Although D-glucose-6 phosphate and D-glucose-1 phosphate were not detected specif-
ically, these results suggest a relatively high rate of AC glycogen biosynthesis. Moreover pyruvate and acetyl-CoA 
levels were elevated in AC (Fig. 3d,e) and the glycolysis and TCA cycle co-factor NAD+ was highly abundant in 
AC (Fig. 3g). Intriguingly, most detected TCA related metabolites showed similar levels in both cell types - an 
exception being significantly higher levels of malate (Fig. 3f) and glutamate (Fig. 3h), other TCA cycle carbon 
sources, in EC. This suggests that under baseline conditions TCA cycle activity is similar in both cells whereas gly-
cogenesis and glycolysis is more predominant in AC. Additional flux analysis will provide more detailed insight 
into cell-specific central carbon metabolism activity.
Injury modulates the AC and EC metabolome differently. Enrichment analysis was next used to 
obtain a global overview of metabolic changes during O2 deprivation. Venn diagrams show the correlations of 
altered metabolites between different degrees of O2 deprivation in the two cell types (Fig. 4a,b). Overall, dur-
ing O2 deprivation 107 metabolites were increased in AC and EC, whereas 45 compounds were decreased. In 
the increased part, AX + Glc caused a stronger induction compared to HX + Glc (Fig. 4a). Furthermore, in AC 
relatively more metabolites were elevated during O2 deprivation, namely 77 metabolites in AC versus 56 in EC 
(Fig. 4a). In contrast, EC had more decreased metabolites compared to AC (31 versus 21 metabolites respec-
tively). Interestingly overall more compounds were decreased during HX + Glc than AX + Glc in EC (Fig. 4b), 
whereas there was more overlap of altered metabolites in AC (Fig. 4a,b). An overview of the pathways enriched 
in EC and AC under AX + Glc generated using KEGG analysis confirmed many more metabolites were altered 
in AC (Fig. S2). The heatmap presents the most enriched pathways in the two cell types under O2 deprivation 
(Fig. 4c). Particularly, carbohydrate metabolism enrichment was relatively higher in AC under mild oxygen depri-
vation (HX + Glc) compared to EC. Furthermore, severe oxygen deprivation (AX + Glc) correlates with enriched 
amino acid, energy and nucleotide metabolism in AC. Pathway enrichment changes during O2 deprivation were 
restricted to only a few different pathways in EC, pointing to a more rigid and less versatile metabolic profile 
compared to AC.
More severe injury conditions were mimicked by combined oxygen and glucose deprivation (OGD). In AC 
132 metabolites were increased compared to only 81 in EC (Fig. 4d). More metabolites were decreased during 
OGD compared to sole O2 deprivation, 157 compounds in AC versus 103 compounds in EC (Fig. 4e). The KEGG 
analyses maps presented in Fig. S3 provide a visual overview of the metabolites most affected by OGD in both 
cells. Together with the heat map in Fig. 4f a dramatic reduction of carbohydrate-related pathways is evident 
in OGD as expected (Figs. 4f and S3). Only amino acid metabolism showed an accumulation of metabolites in 
both cell types. Interestingly, energy and nucleotide metabolism pathways as well as the glutamine/glutamate 
pathway were significantly increased under OGD in AC compared to EC (Fig. 4f). Translation metabolism was 
6SCIENTIFIC REPORTS |         (2020) 10:7760  | https://doi.org/10.1038/s41598-020-64722-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 2. Baseline metabolomic profiles: AC have prominent sugar metabolism whereas EC exhibit strong 
purine and amino acid metabolism. The relationship of metabolite abundance between AC and EC during 
baseline conditions (NX + Glc) using two different pathway analyses. (a) Overview of metabolites highly 
abundant in AC (red) and EC (blue) embedded in their metabolic pathways using MetaboAnalyst (v.4.0) 
and KEGG metabolic pathways tool. The size of the circles represents the fold change with dark and light 
colors depicting significant and non-significant differences respectively. Purple lines represent carbohydrate 
metabolism, red lines nucleotide metabolism, dark green lines lipid metabolism, orange: amino acid 
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also elevated in AC albeit at comparatively lower levels (Fig. 4f). In accordance with O2 deprivation data, we 
again noted that increasing insult severity results in more profound metabolic changes. Taken together, during 
stress conditions differential and distinct metabolic changes occur that probably directly impact adaptation, cell 
behaviour and survival.
Glycogenolysis and glycolysis support AC and EC energy consumption. Since strong changes 
in glycogen/glycolysis metabolism were observed, we further scrutinized the cell-specific mechanisms of cel-
lular energy generation during OGD. Accurate measurement of glucose and glycogen by specific kits were used. 
Unsurprisingly, OGD exhausted cellular glucose levels in both cells although residual levels (20–30% of baseline) 
were always maintained in AC (Figs. 5a and S4a). Whereas AC glycogen levels increased during O2 deprivation, 
OGD completely depleted all glycogen stores (Figs. 5c and S4b). Glycogen was not detectable under any condi-
tion in EC (Figs. 5c and S4b). UDP-glucose levels decreased in a severity-dependent manner for both cell types 
(Fig. 5b). Downstream of glucose metabolism the considerably low normoxic EC pyruvate levels were also rapidly 
depleted but AC pyruvate concentrations, although decreased by OGD, remained at 50–60% (Fig. 5d). In contrast 
acetyl-CoA levels were similar although surprisingly OGD significantly decreased AC stores whereas EC levels 
remained constant (Fig. 5e). Despite these observations the data showed TCA cycle intermediates during OGD 
were comparable in both cells. Levels of oxalosuccinate and 2-oxoglutarate similarly increased in both cell types 
during OGD correlating with the induction of NAD + (Fig. 5f,g). Interestingly, malate levels were decreased in EC 
during severe OGD without a change in oxalacetate levels, indicating that malate levels may contribute to some 
other pathway (Fig. 5f). Despite reduced Acetyl-CoA levels a sharp increase in glutamate and glutamine observed 
solely in AC (Fig. 5h,i) probably contributing to TCA cycling.
AC have a greater adaptive capacity to face environmental stress. Finally we investigated if ATP 
associated metabolites could account for the differential sensitivity of AC and EC to O2 deprivation and OGD as 
we and others previously observed31–33. Accurate measurement of ATP levels was performed with an independent 
assay. Compared to normoxia ATP levels were largely maintained during oxygen deprivation in both cell types 
(Fig. 6a). Increasing ischemia however strongly depleted ATP levels illustrating a reduced capacity to replenish 
stores from alternative energy sources. Notably, EC levels of ADP and particularly AMP were constantly much 
higher than AC in all conditions (Fig. 6b,c). We further compared the abundance of metabolites involved in cre-
atine biosynthesis and creatine (CR) /phosphoCR (pCR) cycle since pCR generation can also stabilize cytosolic 
ATP34. In general levels of glycine, ornithine, and S-adenosyl-L-methionine were up to 2 times higher in AC 
than EC, suggesting a consistently stronger rate of CR biosynthesis (Fig. S5). Supporting this assumption pCR 
levels were also consistently and significantly elevated in AC compared to EC, and remained impressively high 
even after OGD (Fig. 6d). Intriguingly, similarly low CR levels were apparent in both cells during normoxia but 
most injury conditions strongly induced CR in AC, again suggesting its use in replenishing ATP pools. In con-
trast pCR levels were almost undetectable in EC (Fig. 6e) indicating they don’t use pCR to support their energy 
requirements.
Discussion
As metabolic dysregulation plays a prominent role in many brain and vascular-related pathological processes 
associated with BBB disturbance, we hypothesized that differential cell-specific metabolomic adaptation majorly 
influences barrier functionality. This is the first study to directly profile and compare the metabolomes of brain 
EC and AC cells during normoxia and increasingly severe injury conditions. Despite sharing some features, EC 
and AC exhibited distinct normoxic metabolic signatures overall. We noted that AC rapidly respond to environ-
mental stress whereas EC constantly attempt to maintain baseline barrier characteristics. In particular, glycolysis 
and TCA cycle analyses revealed distinct cell-specific metabolomic features and functions in different conditions. 
A schematic overview of energy generation in each cell is shown in Fig. 7.
Differential normoxic metabolic features of AC and brain EC. Published data suggests that all 
non-brain EC exhibit similar metabolic profiles, being highly glycolytic and reliant on β-fatty acid oxidation to 
support their energy usage and balance redox homeostasis8,9. We observed the brain EC metabolomic composi-
tion to be quite different to non-brain EC. Under baseline normoxic conditions nucleotide, amino acid, sulfur as 
well as purine metabolism were highly altered in brain EC. In contrast to non-brain EC carbohydrate metabolism 
and β-fatty acid oxidation was not highly activated. This differential metabolism correlates with the specialized 
function of the brain endothelium. Since glucose is critical for brain function, we suggest that brain EC maintain 
low glucose consumption (glycolysis) to facilitate effective transport across the endothelium. ECs may use glu-
tamate as an alternative fuel to sustain TCA cycling and amino acid metabolism. Indeed, brain EC are resistant 
to glutamate-induced cytotoxicity35 and a highly-activated glutamate metabolism was proposed to help survive 
their special tissue environment and perform their BBB function36,37. This agrees nicely with the fact that we 
detected higher amounts of glutamate in EC compared to AC. Brain EC also exhibited strong purine metabolism, 
presumably to support nucleotide and protein synthesis38–40 and perhaps maintain continuous high expression of 
membrane transporters and tight junction proteins. The AC metabolome was comparatively highly active during 
normoxic conditions with a predominance of glycolytic and central carbon metabolites as observed in previous 
metabolism. n = 4. (b) Heatmap shows the major metabolic pathway activity in different cell types, AC (red) and 
EC (blue), relative to each other. The -Log10(P) value for each pathway was calculated using the MetaboAnalyst 
v.4.0 enrichment analysis tool. n = 4.
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studies22. Levels of pyruvate and the glycolysis co-factor NAD+ were higher in AC, but acetyl-CoA levels were 
similar to EC suggesting most of the pyruvate may contribute to anaerobic glycolysis, lactate and energy genera-
tion in line with observations by others17. Large amounts of glycogen, a readily mobilized form of glucose, were 
measured in AC as expected17,41, but never detected in brain EC. As the highly sensitive isotopomer analyses was 
needed to measure HUVEC levels42, it seems unlikely glycogen is used by EC.
From our data it seems plausible that metabolic interaction between AC and EC is similar to that reported for 
AC and neurons. Indeed high AC glycogen stores and related metabolites mean paracrine energy shuttling could 
significantly benefit all surrounding cells. As the major anti-oxidant producer in the brain, AC also have compar-
atively high basal levels of glutathione (GSH) and NAD+ which are essential for brain redox homeostasis20 and 
β-alanine that boosts GSH synthesis43. We did not utilize co-cultures in this study but our observations neverthe-
less suggest AC and EC likely work together in union. A division of labor with EC particularly focused on barrier 
formation and molecular transportation, and AC supporting nutrient/energy and redox balance would facilitate 
optimal functioning of both the barrier and NVU. Studies investigating such possibilities are now underway.
Figure 3. Energy capacity during normoxic conditions in AC and EC. Levels of metabolites that participate in 
glycogen synthesis; glucose (a), UDP-glucose (b) and glycogen (c). Histograms with hatched pattern show cellular 
glucose and glycogen levels detected by specific and independent quantitative biochemical analysis. The levels of 
pyruvate (d) and abundance of metabolites in TCA cycle (e, f). Levels of NAD + a co-factor of glycolysis (g) and 
glutamate (h), another carbon source of the TCA cycle. EC compared to AC under baseline conditions (NX + Glc). 
n = 4. *P < 0.05, **P < 0.01, ***P < 0.001; unpaired student’s t-test. N.D. not determined. Mean ± SD. n = 4.
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Figure 4. Injury modulates the AC and EC metabolome differently. Venn diagrams show correlations of 
increased (a,d) and decreased (b,e) metabolites between AC and EC after 24 h hypoxic (HX + Glc) and 
anoxic (AX + Glc) stress conditions and during 24 h oxygen-glucose deprivation (HX-Glc) and (AX-Glc). 
(c,f) Heatmaps show comparison of differentially activated metabolic pathways (up and down regulated) 
after oxygen deprivation (c) and OGD (f) in AC (red) and EC (blue). Metabolites were considered increased 
or decreased based on the intensity fold change (upregulated pathways greater than 1.3 or downregulated 
pathways lower than −1.3) compared to NX + Glc. The –Log10(P) was calculated using the MetaboAnalyst 
v.4.0 enrichment analysis tool. n = 4.
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Figure 5. Glycogenolysis and glycolysis support AC and EC energy generation differently. AC and EC levels 
of metabolites that participate in glycogen synthesis; glucose (a), UDP-glucose (b) and glycogen (c). Hatched 
histograms highlight metabolites detected by independent and specific quantitative biochemical analysis. The 
levels of pyruvate (d) and abundance of metabolites in TCA cycle (e,f). Levels of NAD + a co-factor of glycolysis 
(g), glutamate (h) and glutamine (i), other carbon sources of the TCA cycle. AC and EC were exposed to 
normoxia (NX), hypoxia (HX) and near anoxia (AX) without glucose (-Glc) for 24 h. All conditions compared 
to their own control conditions (NX + Glc). N = 4. *P < 0.05, **P < 0.01, ***P < 0.001; 1-way ANOVA. N.D. 
not determined. Data presented as mean ± SD of n = 4.
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Figure 6. AC have a greater adaptive capacity to face environmental stress. Modulation of cellular ATP 
concentrations under different conditions. Abundance of ATP cycle-related metabolites, ADP (b) and AMP (c) 
under different conditions. d,e Amount of creatine (d) and phosphocreatine (e) under different conditions. AC 
and EC were exposed to normoxia (NX), hypoxia (HX) and near anoxia (AX) with or without glucose (±Glc) 
for 24 h. Data compared to baseline conditions (NX + Glc) in each cell type. The ATP data presented as mean ± 
SD of n = 3 (in EC) and n = 7 (in AC) independent experiments, and the LC-MS data showed as mean ± SD of 
n = 4 biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001; 1-way ANOVA.
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Figure 7. Schematic overview of energy generation by AC and EC. We propose the following cellular models 
of energy generation; (a) Under normoxic/resting conditions, AC predominantly use glucose to support 
glycogenesis and anaerobic glycolysis (green) as well as the TCA cycle (purple) via pyruvate synthesis. Brain EC 
sparingly utilize glucose directly to support glycolysis, but glutamate and/or β-oxidation likely contribute to EC 
TCA cycle to maintain the central carbohydrate metabolism. (b) During injury conditions, elevated glycogen 
and pyruvate reserves, pCR as well as excellent antioxidant capacity in AC demonstrate a high metabolic 
flexibility. Comparatively EC are more metabolically rigid, attempting to sustain their resting/baseline profile 
at almost all cost. Arrow thickness represents the degree of pathway activity. The number of repeated circles 
(NAD + ) and rectangles (ATP and CR) indicate the metabolite level. Metabolite abundance is indicated by 
rectangle transparency with dark and light depicting high and low levels respectively under different conditions. 
The dotted arrow indicates inactivated pathways.
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During injury AC dynamically modulate their metabolism whereas brain EC are less flexi-
ble. Prolonged oxygen deprivation significantly impairs BBB stability but perivascular cells are known to have 
higher tolerance to hypoxia than brain EC31–33. Interestingly even mild oxygen deprivation (HX + Glc) altered 
the metabolomic composition of both EC and AC, albeit differentially. Surprisingly, brain EC glycolytic path-
ways remained unchanged during injury conditions suggesting they preferentially spare energy consumption in 
contrast to non-brain EC that induce glycolysis to facilitate energy replenishment during proliferative processes 
and hypoxia-induced angiogenesis9,12,44 - an intriguing fundamental difference. During AX + Glc, EC purine 
metabolites were further decreased suggesting limited investment in DNA and protein synthesis to compensate 
reduced energy availability. In comparison, AC exhibited a much more dynamic response. Oxygen deprivation 
decreased amino acid and TCA related metabolites in correlation with increased glycolytic metabolism as pre-
viously shown45,46. Highly elevated nitrogen, sulfur and nucleotide metabolism was also observed. Thus despite 
becoming more glycolytic AC retain the capacity to mobilize energy consuming pathways.
Unsurprisingly, levels of carbohydrate-related metabolites declined in both cells during OGD. However the 
particularly striking decrease across the EC metabolome in correlation with increasing injury severity suggest a 
progressive functional decline. Indeed significantly reduced nitrogen, sulfur and nucleotide metabolism was sug-
gested to preempt the onset of cell death47,48. In contrast, OGD dramatically elevated select AC amino acid, sulfur, 
nitrogen and nucleotide metabolites in line with induction of non-carbohydrate pathways to support energy gener-
ation during severe stress49. AC also boosted glycolysis pathways while EC preferentially maintained TCA cycling. 
As glycogen is rapidly consumed during glucose deprivation50 pyruvate is likely a major contributor to AC anaer-
obic glycolysis under ischemic conditions18,51. Notably, AC pyruvate levels always remained dramatically higher 
than those of EC, an observation in line with our “glucose-sparing” hypothesis for the brain endothelium. Glucose 
withdrawal might also push AC to utilize more glutamate (increase its turnover) as an alternative carbon source as 
observed in glioma cells52. Increased glutamate and glutamine-related metabolites, and maintenance of both car-
bohydrate (glycolysis and TCA cycle) and amino acid levels, agrees with such responses supporting ischemic AC 
metabolic homeostasis53. Intriguingly, and perhaps counter-intuitively, levels of TCA cycle metabolites were similar 
in both cells. Indeed despite very low pyruvate levels and ongoing stress, brain EC acetyl-CoA and TCA related 
metabolites were constantly maintained at baseline normoxic levels. It is very tempting to speculate that β-fatty acid 
oxidation and amino acid metabolism contribute to EC acetyl-CoA synthesis during ischemia. Interestingly, driving 
the TCA cycle in such a way would bring the brain EC metabolic profile closer to that of resting/quiescent peripheral 
EC. Strikingly, a very recent study showed that diseases associated with BBB disruption exhibit a core transcriptomic 
dysfunction module that shifts brain ECs into a peripheral EC-like state54. Integrating such transcriptomic and 
metabolomic data will provide unprecedented insight into potential ways to modulate BBB. Taken together it seems 
BBB EC are metabolically distinct from non-brain EC by constantly resisting environmental stress to sustain their 
“physiological” characteristics - a feature to preserve barrier homeostasis as long as possible. This largely inflexible 
and stoic profile completely contrasts with the intrinsic dynamic diversity of the AC metabolome.
Creatine/phosphocreatine cycling correlates with AC ability to tolerate severe stress con-
ditions. Creatine (CR) is essential to rapidly replenish ATP in high energy-expending organs such as brain. 
Phosphocreatine (pCR) depletion and induction of its associated pathway correlated with injury severity highlight-
ing that compensatory shifts in this phospho-transfer network likely safeguard AC energetic homeostasis and is 
an important resource55,56. As CR and pCR levels were almost undetectable in EC it was unexpected that cytosolic 
ATP levels were always comparable in both cells. A CR kinase knockout mouse also maintained normal ATP lev-
els57 showing CR/pCR may not always contribute to intracellular ATP pools per se. Presumably high levels of AMP, 
acetyl-CoA and TCA cycle metabolites in brain EC supports energy generation similar to non-brain EC mech-
anisms58. Consistently elevated ADP and AMP levels and activation of high-energy requiring pathways, even in 
baseline conditions, confirmed brain EC are high-energy consumers compared to AC. As maintaining the large 
number of EC mitochondria is surely a major energy drain, the dramatic decrease in AMP and ADP levels during 
severe OGD is probably partially provoked by cell stress from constant mitochondrial activity59. Thus despite their 
ATP turnover likely exceeding that of AC the CR/pCR system is not an available EC resource. Conversely, stressed 
AC gradually increase AMP and ADP levels, nicely correlating with better energy reserves and flexibility. It is highly 
feasible that AC-driven CR secretion benefits brain vascular function as observed between AC and neurons34.
This study provides the first detailed comparison of AC and EC metabolomic profiles under different injury 
conditions. Overall, the distinct cell-specific portraits reflect their important roles within the NVU during brain 
vascular (BBB) homeostasis and disturbance. A schematic overview is provided in Fig. 7a,b. It is undeniable that 
more detailed insight of AC and EC processes, demands and adaptability/flexibility could provide innovative 
ways to modulate barrier permeability. In this regard use of increasingly severe injury conditions in this study was 
strategic as the degree of hypoxic and oxidative stress likely varies considerably between brain regions during dis-
ease - and thereby presumably impacts barrier cells in those regions differently. Thus while it is unclear how our 
injury simulations correspond to environmental conditions during disease processes per se, comparing different 
severities unveils modulations that may occur during diverse scenarios60. We remain mindful that cellular organi-
zation and interactions that occur in vivo, extracellular matrix composition as well as blood flow, are absent in this 
simplified model. As such it is possible the metabolomic responses observed herein will be modified in vivo – but 
which ones and the extent of modification requires further testing. Indeed whether any of these cell-specific alter-
ations definitively contribute to changes in BBB function and EC dysfunction during disease processes remains 
to be tested. It will also be intriguing to explore if metabolite supplementation could have therapeutic potential in 
counteracting progression of such diseases. Overall, it seems poignantly clear that the extensive reserve capacity 
and flexible disposition of AC implies metabolic crosstalk with stressed EC is very likely. As such combining iso-
topic or other tracers to specifically track metabolite shuttling will be essential to fully understand how metabo-
lomic change, and exchange, impact BBB homeostasis. However, if frequent shuttling occurs such alterations will 
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be difficult to track in vitro and be even more challenging to observe in vivo. Prior insight of potentially relevant 
metabolites as presented herein will undoubtedly be valuable.
In conclusion, this comprehensive dataset is a rich resource that presents novel insight into cell-specific meta-
bolic changes and pathways that might impact vascular stability during diverse injury scenarios.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on request.
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